| HOME >> BIOLOGY >> TECHNOLOGY |
ended June 30, 2011ended June 30, 2010(unaudited)GAAPAdjustmentsNon-GAAPGAAPAdjustmentsNon-GAAPRevenues
$
,837,029
$
4,567
(2)
$
,841,596$
,788,675
$
3,877
(2)
$
,792,552Cost of revenues
640,778
(722)
(3)
640,056574,754
(522)
(3)
574,232Purchased intangibles amortization
152,627
(152,627)
(4)-140,137
(140,137)
(4)-Gross profit
1,043,624
157,9161,201,5401,073,784
144,5361,218,320Gross margin
56.8%65.2%60.0%68.0%Operating expenses:Selling, general and administrative
507,606
(3,740)
(5)
503,866512,499
(3,864)
(5)
508,635Research and development
183,859
(1,779)
(5)
182,080176,697
(1,332)
(5)
175,365Purchased in-process research and development
-
--1,650
(1,650)
(4)
-Business consolidation costs
33,349
(33,349)
(6)-48,712
(48,712)
(6)-Total operating expenses
724,814
(38,868)685,946739,558
(55,558)684,000Operating income
318,810
196,784515,594334,226
200,094534,320Operating margin
17.4%28.0%18.7%29.8%Interest income
2,040
-2,0402,452
-2,452Interest expense
(85,919)
17,558
(7)
(68,361)(80,827)
22,491
(7)
(58,336)Loss on early retirement of debt
-
--(54,185)
54,185
(8)
-Gain on divestiture of equity investments
-
--37,260
(37,260)
(9)
-Other income (expense), net
(4,941)-(4,941)(1,977)
6,463
(10)
4,486Total other income (expense), net
(88,820)
<| SOURCE Life Technologies Corporation Copyright©2010 PR Newswire. All rights reserved |